{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T02:07:21Z","timestamp":1768010841991,"version":"3.49.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T00:00:00Z","timestamp":1522108800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000940","name":"Arthritis Australia","doi-asserted-by":"publisher","award":["2018 Arthritis Australia Grant"],"award-info":[{"award-number":["2018 Arthritis Australia Grant"]}],"id":[{"id":"10.13039\/501100000940","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Stephen Hall","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13063-018-2565-z","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T00:29:58Z","timestamp":1522801798000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Outcome Measures in Rheumatology - Interventions for medication Adherence (OMERACT-Adherence) Core Domain Set for Trials of Interventions for Medication Adherence in Rheumatology: 5 Phase Study Protocol"],"prefix":"10.1186","volume":"19","author":[{"name":"On behalf of the OMERACT-Adherence Group","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3325-3840","authenticated-orcid":false,"given":"Ayano","family":"Kelly","sequence":"first","affiliation":[]},{"given":"Allison","family":"Tong","sequence":"additional","affiliation":[]},{"given":"Kathleen","family":"Tymms","sequence":"additional","affiliation":[]},{"given":"Lyn","family":"March","sequence":"additional","affiliation":[]},{"given":"Jonathan C.","family":"Craig","sequence":"additional","affiliation":[]},{"given":"Mary","family":"De Vera","sequence":"additional","affiliation":[]},{"given":"Vicki","family":"Evans","sequence":"additional","affiliation":[]},{"given":"Geraldine","family":"Hassett","sequence":"additional","affiliation":[]},{"given":"Karine","family":"Toupin-April","sequence":"additional","affiliation":[]},{"given":"Bart","family":"van den Bemt","sequence":"additional","affiliation":[]},{"given":"Armando","family":"Teixeira-Pinto","sequence":"additional","affiliation":[]},{"given":"Rieke","family":"Alten","sequence":"additional","affiliation":[]},{"given":"Susan J.","family":"Bartlett","sequence":"additional","affiliation":[]},{"given":"Willemina","family":"Campbell","sequence":"additional","affiliation":[]},{"given":"Therese","family":"Dawson","sequence":"additional","affiliation":[]},{"given":"Michael","family":"Gill","sequence":"additional","affiliation":[]},{"given":"Renske","family":"Hebing","sequence":"additional","affiliation":[]},{"given":"Alexa","family":"Meara","sequence":"additional","affiliation":[]},{"given":"Robby","family":"Nieuwlaat","sequence":"additional","affiliation":[]},{"given":"Yomei","family":"Shaw","sequence":"additional","affiliation":[]},{"given":"Jasvinder A.","family":"Singh","sequence":"additional","affiliation":[]},{"given":"Maria","family":"Suarez-Almazor","sequence":"additional","affiliation":[]},{"given":"Daniel","family":"Sumpton","sequence":"additional","affiliation":[]},{"given":"Peter","family":"Wong","sequence":"additional","affiliation":[]},{"given":"Robin","family":"Christensen","sequence":"additional","affiliation":[]},{"given":"Dorcas","family":"Beaton","sequence":"additional","affiliation":[]},{"given":"Maarten","family":"de Wit","sequence":"additional","affiliation":[]},{"given":"Peter","family":"Tugwell","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,3,27]]},"reference":[{"issue":"8","key":"2565_CR1","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1136\/annrheumdis-2013-204680","volume":"73","author":"E Smith","year":"2014","unstructured":"Smith E, Hoy DG, Cross M, Vos T, Naghavi M, Buchbinder R, et al. The global burden of other musculoskeletal disorders: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis. 2014;73(8):1462\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"2565_CR2","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1186\/ar3224","volume":"13","author":"PP Tak","year":"2011","unstructured":"Tak PP, Kalden JR. Advances in rheumatology: new targeted therapeutics. Arthritis Res Ther. 2011;13(1):S5.","journal-title":"Arthritis Res Ther"},{"issue":"9773","key":"2565_CR3","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/S0140-6736(10)62349-5","volume":"377","author":"TD Rachner","year":"2011","unstructured":"Rachner TD, Khosla S, Hofbauer LC. Osteoporosis: now and the future. Lancet. 2011;377(9773):1276\u201387.","journal-title":"Lancet"},{"issue":"2","key":"2565_CR4","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1093\/rheumatology\/ken457","volume":"48","author":"H Schumacher Jr","year":"2009","unstructured":"Schumacher H Jr, Becker M, Lloyd E, MacDonald P, Lademacher C. Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study. Rheumatology. 2009;48(2):188\u201394.","journal-title":"Rheumatology"},{"issue":"4","key":"2565_CR5","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1210\/jc.2010-2730","volume":"96","author":"JR Center","year":"2011","unstructured":"Center JR, Bliuc D, Nguyen ND, Nguyen TV, Eisman JA. Osteoporosis medication and reduced mortality risk in elderly women and men. J Clin Endocrinol Metab. 2011;96(4):1006\u201314.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2565_CR6","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1590\/S1516-31802010000500013","volume":"128","author":"JA Singh","year":"2010","unstructured":"Singh JA, Christensen R, Wells GA, Suarez-Almazor ME, Buchbinder R, Lopez-Olivo MA, et al. Biologics for rheumatoid arthritis: an overview of Cochrane reviews. Sao Paulo Med J. 2010;128(5):309\u201310.","journal-title":"Sao Paulo Med J"},{"issue":"5","key":"2565_CR7","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1136\/ard.2006.062497","volume":"66","author":"LT Jacobsson","year":"2007","unstructured":"Jacobsson LT, Turesson C, Nilsson J-\u00c5, Petersson IF, Lindqvist E, Saxne T, et al. Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritis. Ann Rheum Dis. 2007;66(5):670\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"2565_CR8","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1002\/acr.22336","volume":"66","author":"MA Vera","year":"2014","unstructured":"Vera MA, Marcotte G, Rai S, Galo JS, Bhole V. Medication adherence in gout: a systematic review. Arthritis Care Res. 2014;66(10):1551\u20139.","journal-title":"Arthritis Care Res"},{"issue":"4","key":"2565_CR9","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1586\/eci.12.23","volume":"8","author":"BJ Van Den Bemt","year":"2012","unstructured":"Van Den Bemt BJ, Zwikker HE, Van Den Ende CH. Medication adherence in patients with rheumatoid arthritis: a critical appraisal of the existing literature. Expert Rev Clin Immunol. 2012;8(4):337\u201351.","journal-title":"Expert Rev Clin Immunol"},{"issue":"12","key":"2565_CR10","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/S0025-6196(11)61093-8","volume":"82","author":"P Kothawala","year":"2007","unstructured":"Kothawala P, Badamgarav E, Ryu S, Miller RM, Halbert R. Systematic review and meta-analysis of real-world adherence to drug therapy for osteoporosis. Mayo Clin Proc. 2007;82(12):1493\u2013501.","journal-title":"Mayo Clin Proc"},{"key":"2565_CR11","doi-asserted-by":"publisher","unstructured":"Kelly A, Tymms K, Tunnicliffe D, Sumpton D, Perera C, Fallon K, et al. Patients\u2019 attitudes and experiences of disease-modifying anti-rheumatic drugs in rheumatoid arthritis and spondyloarthritis; a qualitative synthesis. Arthritis Care Res. 2017; https:\/\/doi.org\/10.1002\/acr.23329 .","DOI":"10.1002\/acr.23329"},{"issue":"3","key":"2565_CR12","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1097\/RHU.0000000000000091","volume":"20","author":"JA Singh","year":"2014","unstructured":"Singh JA. Challenges faced by patients in gout treatment: a qualitative study. J Clin Rheumatol. 2014;20(3):172.","journal-title":"J Clin Rheumatol"},{"issue":"1","key":"2565_CR13","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/1471-2474-12-92","volume":"12","author":"JE Sale","year":"2011","unstructured":"Sale JE, Gignac MA, Hawker G, Frankel L, Beaton D, Bogoch E, et al. Decision to take osteoporosis medication in patients who have had a fracture and are \u2018high\u2019 risk for future fracture: a qualitative study. BMC Musculoskelet Disord. 2011;12(1):92.","journal-title":"BMC Musculoskelet Disord"},{"key":"2565_CR14","doi-asserted-by":"publisher","first-page":"871","DOI":"10.2147\/PPA.S36195","volume":"6","author":"AJ Linn","year":"2012","unstructured":"Linn AJ, van Weert JC, Schouten BC, Smit EG, van Bodegraven AA, van Dijk L. Words that make pills easier to swallow: a communication typology to address practical and perceptual barriers to medication intake behavior. Patient Prefer Adher. 2012;6:871\u201385.","journal-title":"Patient Prefer Adher"},{"issue":"5","key":"2565_CR15","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1365-2125.2012.04167.x","volume":"73","author":"B Vrijens","year":"2012","unstructured":"Vrijens B, De Geest S, Hughes DA, Przemyslaw K, Demonceau J, Ruppar T, et al. A new taxonomy for describing and defining adherence to medications. Bri J Clin Pharmacol. 2012;73(5):691\u2013705.","journal-title":"Bri J Clin Pharmacol"},{"issue":"2","key":"2565_CR16","doi-asserted-by":"publisher","first-page":"e013496","DOI":"10.1136\/bmjopen-2016-013496","volume":"7","author":"R Helmy","year":"2017","unstructured":"Helmy R, Zullig L, Dunbar-Jacob J, Hughes D, Vrijens B, Wilson I, et al. ESPACOMP Medication Adherence Reporting Guidelines (EMERGE): a reactive-Delphi study protocol. BMJ Open. 2017;7(2):e013496.","journal-title":"BMJ Open"},{"key":"2565_CR17","unstructured":"Sabat\u00e9 E. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003."},{"issue":"7212","key":"2565_CR18","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1136\/bmj.319.7212.787","volume":"319","author":"D Dickinson","year":"1999","unstructured":"Dickinson D, Wilkie P, Harris M. Taking medicines: concordance is not compliance. BMJ. 1999;319(7212):787.","journal-title":"BMJ"},{"issue":"1","key":"2565_CR19","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1748-5908-6-42","volume":"6","author":"S Michie","year":"2011","unstructured":"Michie S, van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci. 2011;6(1):42.","journal-title":"Implement Sci"},{"issue":"4","key":"2565_CR20","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1136\/annrheumdis-2014-206593","volume":"75","author":"JS Galo","year":"2016","unstructured":"Galo JS, Mehat P, Rai SK, Avina-Zubieta A, De Vera MA. What are the effects of medication adherence interventions in rheumatic diseases: a systematic review. Ann Rheum Dis. 2016;75(4):667\u201373.","journal-title":"Ann Rheum Dis"},{"key":"2565_CR21","doi-asserted-by":"publisher","unstructured":"Nieuwlaat R, Wilczynski N, Navarro T, Hobson N, Jeffery R, Keepanasseril A, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2014;11:CD000011. https:\/\/doi.org\/10.1002\/14651858.CD000011.pub4","DOI":"10.1002\/14651858.CD000011.pub4"},{"key":"2565_CR22","unstructured":"Boers M, Kirwan JR, Tugwell P. The OMERACT handbook. Canada: OMERACT; 2016."},{"issue":"3","key":"2565_CR23","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s13063-017-1978-4","volume":"18","author":"PR Williamson","year":"2017","unstructured":"Williamson PR, Altman DG, Bagley H, Barnes KL, Blazeby JM, Brookes ST, et al. The COMET Handbook: version 1.0. Trials. 2017;18(3):280.","journal-title":"Trials"},{"key":"2565_CR24","unstructured":"OMERACT Initiative. Outcome Measures in Rheumatology. http:\/\/www.omeract.org . Accessed 25 Aug 2017."},{"key":"2565_CR25","doi-asserted-by":"publisher","first-page":"j2262","DOI":"10.1136\/bmj.j2262","volume":"357","author":"JJ Kirkham","year":"2017","unstructured":"Kirkham JJ, Clarke M, Williamson PR. A methodological approach for assessing the uptake of core outcome sets using ClinicalTrials.gov: findings from a review of randomised controlled trials of rheumatoid arthritis. BMJ. 2017;357:j2262.","journal-title":"BMJ"},{"issue":"8","key":"2565_CR26","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.3899\/jrheum.110406","volume":"38","author":"R Buchbinder","year":"2011","unstructured":"Buchbinder R, Batterham R, Ciciriello S, Newman S, Horgan B, Ueffing E, et al. Health literacy: what is it and why is it important to measure? J Rheumatol. 2011;38(8):1791\u20137.","journal-title":"J Rheumatol"},{"issue":"12","key":"2565_CR27","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.3899\/jrheum.141205","volume":"42","author":"K Toupin-April","year":"2015","unstructured":"Toupin-April K, Barton J, Fraenkel L, Li L, Grandpierre V, Guillemin F, et al. Development of a draft core set of domains for measuring shared decision making in osteoarthritis: an OMERACT working group on shared decision making. J Rheumatol. 2015;42(12):2442\u20137.","journal-title":"J Rheumatol"},{"issue":"1","key":"2565_CR28","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3899\/jrheum.130815","volume":"41","author":"K Tang","year":"2014","unstructured":"Tang K, Boonen A, Verstappen SM, Escorpizo R, Luime JJ, Lacaille D, et al. Worker productivity outcome measures: OMERACT filter evidence and agenda for future research. J Rheumatol. 2014;41(1):165\u201376.","journal-title":"J Rheumatol"},{"issue":"1","key":"2565_CR29","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3899\/jrheum.141011","volume":"43","author":"PP Cheung","year":"2016","unstructured":"Cheung PP, de Wit M, Bingham CO 3rd, Kirwan JR, Leong A, March LM, et al. Recommendations for the involvement of patient research partners (PRP) in OMERACT working groups. a report from the OMERACT 2014 Working Group on PRP. J Rheumatol. 2016;43(1):187\u201393.","journal-title":"J Rheumatol"},{"key":"2565_CR30","unstructured":"Richards P, De Wit M. The OMERACT glossary for patient research partners. 2004. https:\/\/omeract.org\/resources . Accessed 12 Jan 2018."},{"key":"2565_CR31","unstructured":"Song Initiative. The SONG Handbook. Version 1.0 June 2017, Sydney, Australia. songinitiative.org\/reports-and-publications \/. Accessed 12 Jan 2018."},{"key":"2565_CR32","unstructured":"Kelly A, Sumpton D, O'Sullivan C, Meara A, Nieuwlaat R, Tugwell P, et al. Scope and consistency of adherence related outcomes in randomized controlled trials of interventions for improving medication adherence. Arthritis Rheumatol. 2017;69(S10):1-4481."},{"issue":"6","key":"2565_CR33","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349\u201357.","journal-title":"Int J Qual Health Care"},{"issue":"2","key":"2565_CR34","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77\u2013101.","journal-title":"Qual Res Psychol"},{"issue":"7001","key":"2565_CR35","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1136\/bmj.311.7001.376","volume":"311","author":"J Jones","year":"1995","unstructured":"Jones J, Hunter D. Consensus methods for medical and health services research. BMJ. 1995;311(7001):376.","journal-title":"BMJ"},{"issue":"3","key":"2565_CR36","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1053\/j.ajkd.2016.02.037","volume":"68","author":"R Urquhart-Secord","year":"2016","unstructured":"Urquhart-Secord R, Craig JC, Hemmelgarn B, Tam-Tham H, Manns B, Howell M, et al. Patient and caregiver priorities for outcomes in hemodialysis: an international nominal group technique study. Am J Kidney Dis. 2016;68(3):444\u201354.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"2565_CR37","first-page":"548","volume":"20","author":"BJ Fried","year":"1993","unstructured":"Fried BJ, Boers M, Baker PR. A method for achieving consensus on rheumatoid arthritis outcome measures: the OMERACT conference process. J Rheumatol. 1993;20(3):548\u201351.","journal-title":"J Rheumatol"},{"issue":"4","key":"2565_CR38","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1136\/annrheumdis-2016-210242","volume":"76","author":"AM Orbai","year":"2017","unstructured":"Orbai AM, de Wit M, Mease P, Shea JA, Gossec L, Leung YY, et al. International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials. Ann Rheum Dis. 2017;76(4):673\u201380.","journal-title":"Ann Rheum Dis"},{"key":"2565_CR39","volume-title":"The Delphi method: techniques and applications. Addison-Wesley Reading, MA","author":"HA Linstone","year":"1975","unstructured":"Linstone HA, Turoff M. The Delphi method: techniques and applications. Addison-Wesley Reading, MA; 1975."},{"key":"2565_CR40","doi-asserted-by":"crossref","unstructured":"Bartlett SJ, Hewlett S, Bingham CO, Woodworth TG, Alten R, Pohl C, et al. Identifying core domains to assess flare in rheumatoid arthritis: an OMERACT international patient and provider combined Delphi consensus. Ann Rheum Dis. 2012;71(11):1855\u201360.","DOI":"10.1136\/annrheumdis-2011-201201"},{"issue":"6","key":"2565_CR41","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1136\/ard.2007.079970","volume":"67","author":"WJ Taylor","year":"2008","unstructured":"Taylor WJ, Schumacher HR Jr, Baraf HS, Chapman P, Stamp L, Doherty M, et al. A modified Delphi exercise to determine the extent of consensus with OMERACT outcome domains for studies of acute and chronic gout. Ann Rheum Dis. 2008;67(6):888\u201391.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"2565_CR42","first-page":"501","volume":"34","author":"H Gazi","year":"2007","unstructured":"Gazi H, Pope JE, Clements P, Medsger TA, Martin RW, Merkel PA, et al. Outcome measurements in scleroderma: results from a Delphi exercise. J Rheumatol. 2007;34(3):501\u20139.","journal-title":"J Rheumatol"},{"key":"2565_CR43","doi-asserted-by":"crossref","unstructured":"Toupin-April K, Barton J, Fraenkel L, Li LC, Brooks P, De Wit M, et al. Toward the Development of a Core Set of Outcome Domains to Assess Shared Decision-making Interventions in Rheumatology: Results from an OMERACT Delphi Survey and Consensus Meeting. J Rheumatol. 2017;44(10):1544-50.","DOI":"10.3899\/jrheum.161241"},{"issue":"1","key":"2565_CR44","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1471-2288-5-37","volume":"5","author":"RB Akins","year":"2005","unstructured":"Akins RB, Tolson H, Cole BR. Stability of response characteristics of a Delphi panel: application of bootstrap data expansion. BMC Med Res Methodol. 2005;5(1):37.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"2565_CR45","doi-asserted-by":"publisher","first-page":"e1000393","DOI":"10.1371\/journal.pmed.1000393","volume":"8","author":"IP Sinha","year":"2011","unstructured":"Sinha IP, Smyth RL, Williamson PR. Using the Delphi technique to determine which outcomes to measure in clinical trials: recommendations for the future based on a systematic review of existing studies. PLoS Med. 2011;8(1):e1000393.","journal-title":"PLoS Med"},{"issue":"1","key":"2565_CR46","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jhealeco.2006.04.002","volume":"26","author":"TN Flynn","year":"2007","unstructured":"Flynn TN, Louviere JJ, Peters TJ, Coast J. Best\u2013worst scaling: what it can do for health care research and how to do it. J Health Econ. 2007;26(1):171\u201389.","journal-title":"J Health Econ"},{"issue":"7","key":"2565_CR47","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.jclinepi.2013.11.013","volume":"67","author":"M Boers","year":"2014","unstructured":"Boers M, Kirwan JR, Wells G, Beaton D, Gossec L, d'Agostino MA, et al. Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0. J Clin Epidemiol. 2014;67(7):745\u201353.","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"2565_CR48","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1590\/bjpt-rbf.2014.0143","volume":"20","author":"LB Mokkink","year":"2016","unstructured":"Mokkink LB, Prinsen CA, Bouter LM, de Vet HC, Terwee CB. The Consensus-based Standards for the Selection of Health Measurement Instruments (COSMIN) and how to select an outcome measurement instrument. Braz J Phys Ther. 2016;20(2):105\u201313.","journal-title":"Braz J Phys Ther"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-018-2565-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-018-2565-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-018-2565-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,13]],"date-time":"2019-10-13T22:08:37Z","timestamp":1571004517000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-018-2565-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,27]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2565"],"URL":"https:\/\/doi.org\/10.1186\/s13063-018-2565-z","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,27]]},"assertion":[{"value":"29 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Liverpool Hospital, BJC Health (Parramatta and Chatswood), Royal North Shore Hospital (South Western Sydney Local Health District Research and Ethics Office, Locked Bag 7103, Liverpool BC NSW 1871, Australia, approval number HE 16\/373 LNR, approved 2 March 2017), Canberra Hospital and Canberra Rheumatology (Australian Capital Territory Health Human Research Ethics Committee, ACT Government Health Directorate Research Office, Building 10 Level 6, Canberra Hospital, Yamba Drive, Garran ACT 2605, Australia, approval number ETHLR.15.137, approved 11 August 2015) have provided an ethical review and approval for the phase 2 and 3 studies. Ethics approval will be sought for the remainder of the OMERACT study. The primary investigator or co-ordinating investigator at each study site will obtain informed consent from all participants in the study (available on request).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"PT, LM, MDW, DB and JAS are members of the executive of OMERACT, an organisation that develops outcome measures in rheumatology and receives arms-length funding from 36 companies. JAS has received research grants from Takeda and Savient and consultant fees from Savient, Takeda, Regeneron, Merz, Iroko, Bioiberica, Crealta\/Horizon and Allergan Pharmaceuticals, WebMD, UBM LLC and the American College of Rheumatology (ACR). JAS serves as the principal investigator for an investigator-initiated study funded by Horizon Pharmaceuticals through a grant to DINORA, Inc, a 501(c)(3) entity. JAS is a member of the ACR\u2019s Annual Meeting Planning Committee; chair of the ACR Meet-the-Professor, Workshop and Study Group Subcommittee; and a member of the Veterans Affairs Rheumatology Field Advisory Committee. JAS is the editor and the director of the University of Alabama at Birmingham (UAB) Cochrane Musculoskeletal Group Satellite Center on Network Meta-analysis. RC is a member of the Technical Advisory Group for the OMERACT Domain & Instrument Selection Process, which might be perceived as an intellectual conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"204"}}